GUS (compared to RIS) uniquely binds both CD64+ myeloid cells and IL-23. CD64+ mononuclear phagocytes are enriched in the psoriatic skin and serve as the dominant IL-23 source. Does this lead to a change in clinical response? Abs 1487 #ACR22 @RheumNow https://t.co/P512bxSxRn
Links:
Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23 - ACR M…
http://ow.ly/IizW50LyVZV
13-11-2022